Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
All 16 of Indiana’s designated senior care organizations — known as Area Agencies on Aging — are now required to have a ...
Benzinga on MSN7h
Cognition Therapeutics Is Targeting A Critical Form Of DementiaLisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition ...
A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...
The third most common form of dementia is often mistaken for Alzheimer's despite different treatment needsCognitive profiles ...
A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...
Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
2024 saw a new drug enter the dementia landscape, as the U.S. Food and Drug Administration (FDA) approved Kisunla (donanemab) ...
With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer’s disease, the road to a cure seems ...
A University of California, Irvine-led research team has discovered intricate molecular mechanisms driving the RNA processing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback